RMPWM
PFE icon

Rocky Mountain Private Wealth Management’s Pfizer PFE Stock Holding History

Rocky Mountain Private Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$3K Hold
105
– – 2.21% 13
2016
Q2 		$3K Hold
105
– – 1.92% 16
2016
Q1 		$2K Hold
105
– – 1.31% 18
2015
Q4 		$3K Buy
+105
New +$3.3K 2.01% 16

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Rocky Mountain Private Wealth Management's PFE Position: Q3 2016 in Review

Rocky Mountain Private Wealth Management held its Pfizer (PFE) position steady in Q3 2016 at 105 shares worth $3K. The position accounts for 2.21% of the portfolio, ranked #13.

Rocky Mountain Private Wealth Management first reported a position in PFE in Q4 2015 and has held it in 4 quarters since. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

  • Rocky Mountain Private Wealth Management held 105 shares of Pfizer worth $3K as of Q3 2016.
  • Rocky Mountain Private Wealth Management left its Pfizer share count unchanged in Q3 2016.
  • Pfizer made up 2.21% of Rocky Mountain Private Wealth Management's portfolio in Q3 2016, its #13 holding.
  • Rocky Mountain Private Wealth Management first reported a position in Pfizer in Q4 2015 and has held it in 4 quarters since.
  • 1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Rocky Mountain Private Wealth Management's 13F filing for Q3 2016, filed 14 Nov 2016.